• Cell lysis buffer for WB and IP: Streamlined Protein Extract

  2026-07-29

  Unlock reproducible protein extraction across animal, plant, and microbial samples using Cell lysis buffer for WB and IP. This APExBIO solution ensures robust preservation of protein integrity for Western blot, immunoprecipitation, and mechanistic tumor microenvironment studies.

• PBS (Phosphate-Buffered Saline): Technical Use & Protocol Gu

  2026-07-28

  PBS (Phosphate-Buffered Saline, SKU K2818) provides a sterile, isotonic buffer solution for critical tasks such as cell washing and reagent dilution in laboratory research. It ensures physiological pH and osmolarity but is not suitable for diagnostic, clinical, or in vivo applications. Researchers should restrict its use to controlled in vitro experimental workflows.

• Optimized hGBA1-mRNA Therapy Restores Lysosomal GCase in Gau

  2026-07-28

  The reference study presents a rationally engineered human GBA1 mRNA, delivered via lipid nanoparticles, that greatly enhances β-glucocerebrosidase (GCase) expression and lysosomal activity in cellular and mouse models of Gaucher disease. These findings establish optimized mRNA-LNP delivery as a promising alternative to enzyme replacement therapy, with direct implications for advancing lysosomal enzyme activity assays and glycosphingolipid metabolism research.

• Pharmacokinetic Variability of CSBTA in MASH Mouse Models

  2026-07-27

  This study provides an in-depth analysis of how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a high-fat, high-cholesterol diet (HFHCD) mouse model. The findings highlight disease-driven changes in systemic exposure and hepatic accumulation, informing future research on dosing strategies in MASLD/MASH contexts.

• Elevating qPCR Precision: Translational Impact in PDAC Resea

  2026-07-27

  This thought-leadership article explores how mechanistic insights into LRRC8A-CAV1 signaling in pancreatic ductal adenocarcinoma (PDAC) reframe the strategic deployment of real-time PCR technologies. It highlights the role of HotStart™ Universal 2X Green qPCR Master Mix in enabling robust, reproducible gene expression quantification in complex tumor models, while offering actionable guidance for translational researchers. The piece bridges fundamental biology, experimental rigor, and innovative workflow optimization—venturing beyond conventional product overviews.

• Pharmacokinetic Variability of CSBTA in MASH Mouse Models

  2026-07-26

  This study characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By integrating advanced LC-MS/MS profiling with transporter and enzyme assays, the paper reveals disease-driven changes in drug exposure, guiding rational dose optimization for MASLD/MASH therapy.

• CH 223191: An Aryl Hydrocarbon Receptor Antagonist in Ovaria

  2026-07-25

  CH 223191 is a nanomolar-potency aryl hydrocarbon receptor antagonist, enabling precise dissection of AhR signaling in models of environmental toxicant exposure and reproductive toxicity. Its validated selectivity, workflow-optimized solubility, and robust inhibition of dioxin- and phthalate-mediated pathways make it indispensable for mechanistic studies and assay development.

• Dabigatran Etexilate: Direct Thrombin Inhibitor for VTE and

  2026-07-24

  The reference review details the clinical emergence of dabigatran etexilate, the first oral direct thrombin inhibitor (DTI), highlighting its predictable pharmacology, efficacy in VTE and stroke prevention, and advantages over traditional anticoagulants. The findings underscore dabigatran's role in overcoming several practical limitations of vitamin K antagonists and low-molecular-weight heparins in thromboembolic disease management.

• MLN8237 (Alisertib): Applied Protocols for Cancer Biology Re

  2026-07-24

  MLN8237 (Alisertib) unlocks precise control of Aurora A kinase inhibition, enabling robust apoptosis induction in tumor models and dissecting advanced mechanisms in trained immunity. This guide translates the latest mechanistic discoveries and practical workflows into actionable protocols—optimizing your cancer biology assays with data-driven precision.

• 4-Methylumbelliferyl-β-D-Glucopyranoside: Precision Tools fo

  2026-07-23

  Explore the scientific foundations and advanced protocol strategies for 4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) in lysosomal enzyme activity assays. This article uniquely bridges assay optimization with emerging mRNA therapeutics for Gaucher disease.

• Fisetin Inhibits Ferroptosis After Traumatic Brain Injury

  2026-07-23

  Yang et al. demonstrate that fisetin, a naturally occurring flavonoid, exerts neuroprotective effects after traumatic brain injury (TBI) by inhibiting ferroptosis and oxidative stress through PI3K/AKT/NRF2 pathway activation. This work advances understanding of ferroptosis in neurotrauma and highlights a practical in vitro approach using established ferroptosis inducers.

• Standardized Whole-Blood Stimulation for Immunometabolic Ana

  2026-07-22

  This study introduces a reproducible protocol for analyzing immune responses in human whole blood under controlled metabolic modulation. Its approach enables detailed investigation of how metabolic interventions shape cytokine production, providing a robust platform for advancing immunometabolic and translational immunology research.

• α2-Adrenergic Receptor Agonists for Immune Modulation in Ost

  2026-07-22

  The reference study provides compelling evidence that α2-adrenergic receptor agonists, delivered via a thermo-sensitive hydrogel, can reduce post-surgical osteosarcoma recurrence by enhancing immune-mediated tumor rejection. This research highlights a shift from direct cytotoxic strategies to immune microenvironment modulation, offering new directions for targeted bone cancer therapies.

• Fisetin Inhibits Ferroptosis and Oxidative Stress After TBI

  2026-07-21

  Yang et al. (2024) demonstrate that fisetin exerts neuroprotective effects after traumatic brain injury (TBI) by inhibiting ferroptosis and oxidative stress, both in a mouse model and in cultured neural cells. Their integrative approach provides mechanistic insight into ferroptosis as a secondary injury process in TBI and highlights signaling pathways that may be targeted for therapeutic intervention.

• Bifendate (DDB): Applied Workflows for Hepatoprotection Rese

  2026-07-21

  Bifendate (DDB) enables precise modeling of hepatic lipid regulation and autophagy inhibition, setting the standard for in vitro and in vivo liver disease studies. Learn how to optimize DDB usage, avoid common pitfalls, and translate mechanistic insights into robust data with confidence.

724 records 12/49 page Previous Next First page 上5页 1112131415 下5页 Last page